TMCI
Treace Medical Concepts Inc.
$6.39
+$0.04(+0.63%)
40
Overall
60
Value
20
Tech
--
Quality
Market Cap
$420.73M
Volume
202.22K
52W Range
$4.70 - $10.79
Target Price
$8.42
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $94.4M | $141.8M | $187.1M | $209.4M | ||
| Total Revenue | $94.4M | $141.8M | $187.1M | $209.4M | ||
| COST OF GOODS SOLD | ||||||
| Cost of Revenue | $17.8M | $25.5M | $35.2M | $41.1M | ||
| GROSS PROFIT | ||||||
| Gross Profit | $76.6M | $116.3M | $151.9M | $168.3M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $93.1M | $151.2M | $203.4M | $224.0M | ||
| Research & Development | $10.2M | $13.6M | $15.4M | $20.6M | ||
| Research Expense | $10.2M | $13.6M | $15.4M | $20.6M | ||
| Selling, General & Administrative | $82.9M | $137.6M | $187.9M | $203.4M | ||
| Selling & Marketing Expenses | $64.5M | $104.6M | $140.9M | $147.6M | ||
| General & Administrative Expenses | $18.4M | $33.0M | $47.0M | $55.7M | ||
| Promotion & Advertising | $13.0M | -- | -- | -- | ||
| Depreciation & Amortization | $685.0K | $2.1M | -- | -- | ||
| Depreciation & Amortization | $685.0K | -- | -- | -- | ||
| Amortization | $200.0K | $200.0K | $13.1M | $13.1M | ||
| Other Operating Expenses | -- | $403.0K | $-342.0K | $-324.0K | ||
| OPERATING INCOME | ||||||
| Operating income | $-16.5M | $-34.8M | $-51.4M | $-55.7M | ||
| EBITDA | $-15.6M | $-36.0M | $-38.7M | $-41.8M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $4.1M | $4.4M | $5.2M | $5.3M | ||
| Net Non-Operating Interest Income/Expense | $-4.1M | $3.1M | $-5.2M | $-5.3M | ||
| Gain on Sale of Securities | $18.0K | $1.3M | $6.7M | $4.9M | ||
| Other Income/Expense | $-18.0K | $-4.9M | $-6.9M | $-4.8M | ||
| Other Special Charges | $2.3M | $-4.5M | -- | -- | ||
| SPECIAL ITEMS | ||||||
| Special Income Charges | -- | $-300.0K | -- | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-16.5M | $-38.4M | $-44.4M | $-50.5M | ||
| Pre-Tax Income | $-20.5M | $-42.8M | $-49.3M | $-55.7M | ||
| NET INCOME | ||||||
| Net Income | $-20.6M | $-42.8M | $-49.5M | $-55.7M | ||
| Net Income (Continuing Operations) | $-20.6M | $-42.8M | $-49.5M | $-55.7M | ||
| Net Income (Discontinued Operations) | $-20.6M | $-42.8M | $-49.5M | $-55.7M | ||
| Net Income (Common Stockholders) | $-20.7M | $-42.8M | $-49.5M | $-55.7M | ||
| TOTALS | ||||||
| Total Expenses | $110.9M | $176.7M | $238.5M | $265.0M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $48.4M | $55.3M | $60.9M | $62.1M | ||
| Average Shares Outstanding (Diluted) | -- | $55.3M | $60.9M | $62.1M | ||
| Shares Outstanding | $54.7M | $61.2M | $61.8M | $62.6M | ||
| Basic EPS | $-0.43 | $-0.77 | $-0.81 | $-0.90 | ||
| Basic EPS (Continuing Operations) | $-0.43 | $-0.77 | $-0.81 | $-0.90 | ||
| Diluted EPS | $-0.43 | $-0.77 | $-0.81 | $-0.90 | ||
| Diluted EPS (Continuing Operations) | -- | $-0.77 | $-0.81 | $-0.90 | ||
| OTHER METRICS | ||||||
| Accrued Preferred Stock Dividends | $196.0K | -- | -- | -- | ||
| Other Gand A | $18.4M | $33.0M | $47.0M | $55.7M | ||
| Otherunder Preferred Stock Dividend | $196.0K | -- | -- | -- | ||
| Preferred Stock Dividends | $196.0K | -- | -- | -- | ||
| Rent And Landing Fees | $-600.0K | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TMCI | $6.39 | +0.6% | 202.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Treace Medical Concepts Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW